CATALOGO DEI PRODOTTI DELLA RICERCA

TORTORA, GIAMPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.476
EU - Europa 18.023
AS - Asia 13.198
SA - Sud America 1.828
Continente sconosciuto - Info sul continente non disponibili 462
AF - Africa 443
OC - Oceania 44
Totale 56.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.728
RU - Federazione Russa 6.461
SG - Singapore 5.109
GB - Regno Unito 4.623
CN - Cina 4.301
IT - Italia 1.608
BR - Brasile 1.391
VN - Vietnam 1.107
HK - Hong Kong 1.070
DE - Germania 1.023
FR - Francia 995
IE - Irlanda 968
SE - Svezia 954
FI - Finlandia 690
KR - Corea 462
CA - Canada 335
NG - Nigeria 192
BD - Bangladesh 183
IN - India 183
UA - Ucraina 164
AR - Argentina 155
JP - Giappone 137
NL - Olanda 130
ID - Indonesia 107
TR - Turchia 105
MX - Messico 103
ZA - Sudafrica 84
IQ - Iraq 69
EC - Ecuador 68
PL - Polonia 65
ES - Italia 63
CO - Colombia 56
BE - Belgio 55
CR - Costa Rica 47
GT - Guatemala 45
UZ - Uzbekistan 44
MA - Marocco 43
VE - Venezuela 42
CL - Cile 38
HN - Honduras 37
SA - Arabia Saudita 36
AU - Australia 35
PK - Pakistan 34
AT - Austria 33
SV - El Salvador 29
PY - Paraguay 28
EU - Europa 27
JM - Giamaica 27
PH - Filippine 27
TT - Trinidad e Tobago 26
CH - Svizzera 25
NI - Nicaragua 24
PE - Perù 24
MY - Malesia 23
PR - Porto Rico 23
IR - Iran 22
KE - Kenya 22
IL - Israele 21
AE - Emirati Arabi Uniti 20
CW - ???statistics.table.value.countryCode.CW??? 20
LT - Lituania 19
EG - Egitto 18
GP - Guadalupe 18
NP - Nepal 17
JO - Giordania 16
TN - Tunisia 16
UY - Uruguay 16
AL - Albania 15
AZ - Azerbaigian 15
CZ - Repubblica Ceca 15
RO - Romania 13
SC - Seychelles 12
KG - Kirghizistan 11
GR - Grecia 10
DZ - Algeria 9
EE - Estonia 9
KZ - Kazakistan 9
LK - Sri Lanka 9
LV - Lettonia 9
BB - Barbados 8
DK - Danimarca 8
PT - Portogallo 8
BO - Bolivia 7
NZ - Nuova Zelanda 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 6
BJ - Benin 6
BY - Bielorussia 6
HU - Ungheria 6
NO - Norvegia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
LB - Libano 5
LY - Libia 5
PA - Panama 5
QA - Qatar 5
AO - Angola 4
Totale 55.951
Salva come PNG Salva come JPEG
Città #
Southend 4.135
Singapore 2.607
Ashburn 2.521
San Jose 2.077
Moscow 1.973
Chandler 1.828
Dallas 1.632
Jacksonville 1.427
Woodbridge 1.397
Hong Kong 1.056
Ann Arbor 987
Dublin 961
Council Bluffs 827
Beijing 748
The Dalles 700
Verona 674
Houston 621
Lawrence 394
Princeton 393
Wilmington 385
Los Angeles 372
Ho Chi Minh City 343
New York 342
Jinan 321
Nanjing 276
Shenyang 257
Hanoi 227
Santa Clara 208
Tianjin 193
Abuja 190
Munich 189
Buffalo 185
São Paulo 173
Hebei 165
Changsha 136
Redondo Beach 130
Tokyo 120
Helsinki 114
Nanchang 107
Chicago 102
Columbus 101
Milan 99
Zhengzhou 97
Haikou 92
Guangzhou 90
Ningbo 87
Hangzhou 83
Sindelfingen 82
Dong Ket 78
Montreal 78
Jiaxing 75
Brooklyn 74
Orem 74
London 73
Turku 67
Frankfurt am Main 66
San Francisco 65
Denver 61
Taizhou 60
Atlanta 59
Seoul 59
Jakarta 58
Redwood City 58
Norwalk 57
Toronto 56
Taiyuan 55
Brussels 53
Chennai 52
Warsaw 52
Seattle 51
Phoenix 50
Rome 48
Boardman 47
Johannesburg 47
Stockholm 47
Bologna 45
Mexico City 45
Amsterdam 43
Lanzhou 43
Lancaster 40
Fuzhou 39
Tashkent 38
Rio de Janeiro 37
Haiphong 36
Boston 35
Da Nang 35
Falls Church 34
Guatemala City 34
Washington 34
Dearborn 33
San José 33
Charlotte 32
Las Vegas 32
Baghdad 31
Biên Hòa 30
Manchester 30
Naples 30
Kent 29
North Bergen 29
Redmond 29
Totale 34.720
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 327
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 305
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 299
Whole-genome landscape of pancreatic neuroendocrine tumours 297
Genomic analyses identify molecular subtypes of pancreatic cancer 272
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 270
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 268
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 264
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 264
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 257
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 257
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 254
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 251
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 250
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 246
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 244
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 238
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 236
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 235
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 233
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 232
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 227
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 227
Adenocarcinoma of the paraurethral glands: a case report 226
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 224
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 224
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 222
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 220
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 219
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 218
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 217
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 217
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 215
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 214
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 213
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 212
Emerging pathways and future targets for the molecular therapy of pancreatic cancer. 211
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 209
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 208
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 207
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 206
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 206
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 204
Reporting tumor molecular heterogeneity in histopathological diagnosis 204
A novel modified CpG agonist of TLR-9 inhibits EGF receptor signalling and synergistically enhances antitumor activity of cetuximab and irinotecan eradicating colon cancer xenografts 203
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 203
ESGAR 2016 Book of Abstracts 203
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 203
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 202
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 202
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 202
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 201
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 201
A selective cyclooxygenase-2 inhibitor combined with the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') and protein kinase A antisense causes cooperative tumor growth inhibition after oral administration 200
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 200
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 200
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 200
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 200
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 199
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 199
AR-V7 and prostate cancer: The watershed for treatment selection? 198
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 198
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 197
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 197
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 197
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 196
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents. 196
The development of PARP as a successful target for cancer therapy 196
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 196
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 196
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 195
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? 195
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 192
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 190
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 190
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. 189
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 189
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 187
A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in a multi-center series of resected early stage pure invasive lobular breast carcinoma (ILC) 187
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 186
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 185
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 185
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 184
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 184
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 184
Hypermutation In Pancreatic Cancer 183
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 182
8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. 182
AGENTI BIOLOGICI e CHEMIOTERAPICI: INTEGRAZIONE 181
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 180
Molecular Pathology of Pancreatic Cancer: from bench-to-bedside translation. 179
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 178
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 178
2015 and human cancer: back to overall survival 177
Local ablation disrupts immune evasion in pancreatic cancer 176
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 175
Metabolic phenotype of bladder cancer 174
Metabolic alterations in renal cell carcinoma 173
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 173
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 172
Totale 21.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.310
article - articoli 177.347
book - libri 533
conference - conferenze 13.290
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.140
Totale 390.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.510 0 0 0 0 94 46 41 174 108 61 197 789
2022/20235.437 469 501 551 850 526 1.398 53 318 576 36 115 44
2023/20242.389 103 200 174 200 378 379 50 232 45 124 352 152
2024/20257.232 397 442 237 1.307 251 195 248 308 1.231 484 581 1.551
2025/202621.296 1.649 1.067 1.714 3.532 5.200 1.271 1.992 1.095 1.668 1.120 339 649
2026/20273.947 179 604 873 2.211 80 0 0 0 0 0 0 0
Totale 56.474